SEC Form 4 · accession 0001437749-26-030343
TG THERAPEUTICS, INC. · TGTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laurence N Charney
Director
Period of report
Sep 10, 2026
Accepted (ET)
Sep 14, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001001316
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Sep 10, 2026 | S | 5,000 | $54.96 | D | 168,640 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Charney's income tax obligations.
- F2Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $54.92 to $54.99. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3Includes shares of restricted Common Stock, which vest over various time periods.